Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. J Gastrointest Oncol. 2019 Aug;10(4):674-87. doi: 10.21037/jgo.2019.03.11
Cates S, Santiago OJ, Hersey J, Blitstein J, Kosa K, Singh A, Berman D. Eat Smart, Live Strong intervention increases fruit and vegetable consumption among low-income older adults. Poster presented at the 2014 Society for Nutrition Education and Behavior Conference; July 2014. Milwaukee, WI. [abstract] J Nutr Educ Behav. 2014 Jul; 46(4):S103-4. doi: 10.1016/j.jneb.2014.04.025
Shakoor A, Esterberg E, Acharya NR. Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm. 2014 Apr;22(2):96-101. doi: 10.3109/09273948.2013.812222
Martel JN, Esterberg E, Nagpal A, Acharya NR. Infliximab and adalimumab for uveitis. Ocul Immunol Inflamm. 2012 Feb;20(1):18-26. doi: 10.3109/09273948.2011.633205.
Jeuland M, Maskery B, Cook J, Poulos C, Clemens J, Lauria D, Stewart J, Lucas M, Whittington D. Incorporating cholera vaccine herd protection into economic cost-benefit and cost-effectiveness models. Procedia Vaccinol. 2010;2(2010):140-6. doi: 10.1016/j.provac.2010.07.006
Anderson DW, Calingaert B. Changes in meat and poultry nutrition labeling regulations: implications for nutrition educators. J Nutr Educ Behav. 1994 Jan;26(1):15-9. doi: 10.1016/S0022-3182(12)80829-6